Table 2 FAS expression and preoperative parameters
FAS expression | ||||
|---|---|---|---|---|
Parameters | Patients | Low | High | P value |
Clinical T stage | ||||
cT1c | 71 | 31 | 40 | 0.0381 |
cT2-cT3 | 31 | 7 | 24 | |
PSA (ng/ml) | ||||
≤ 10 | 60 | 24 | 36 | 0.4919 |
10 < | 42 | 14 | 28 | |
Needle biopsy Gleason score | ||||
≤ 6 | 31 | 18 | 13 | 0.0044 |
7 ≤ | 71 | 20 | 51 | |
Positive core rate (%) | ||||
≤ 40 | 72 | 33 | 39 | 0.0038 |
40 < | 30 | 5 | 25 | |
D’Amico risk classification | ||||
Low and Intermediate risk | 67 | 28 | 39 | 0.1853 |
High risk | 35 | 10 | 25 | |